NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
04/29/2025
Back to search
Official data from USPTO
SALONPAS LIDOCAINE PLUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
04/30/2025
Trademark type
Combined
Nice classes
5
Filing date
05/30/2017
Registration date
06/19/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/06/2024
Last transaction
04/30/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/01/2017
First use in commerce
09/01/2017
Drawing code
3
Owner type
03
Owner location
Tosu-shi, Saga, JP
Examiner
YI,CRYSTAL HAEIN
Current location
Historical data usage
Mark description
The mark consists of the word "SALONPAS" in white stylized lettering carried on a blue banner having a green top and bottom over the word "LIDOCAINE" depicted in blue and "PLUS" depicted in green.
Holders and representatives
Holders
Hisamitsu Pharmaceutical Co., Inc.
Representatives
Kazuyo Morita HOLLAND & HART LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicated creams and liquid all containing lidocaine for pain relief; pharmaceutical preparations containing lidocaine for pain relief; topical anesthetics containing lidocaine
Publications
History of USPTO decisions and trademark events.
34 publications found
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/07/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/06/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/06/2024
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
11/06/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/01/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
05/13/2024
E815
TEAS SECTION 8 & 15 RECEIVED
05/13/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/19/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/19/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2018
PUBO
PUBLISHED FOR OPPOSITION
04/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/14/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/26/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/23/2018
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
02/23/2018
IUAA
USE AMENDMENT ACCEPTED
02/22/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/22/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/22/2018
ALIE
ASSIGNED TO LIE
02/19/2018
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/10/2018
IUAF
USE AMENDMENT FILED
02/10/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2018
EAAU
TEAS AMENDMENT OF USE RECEIVED
02/09/2018
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
10/04/2017
GPRA
PRIORITY ACTION E-MAILED
10/04/2017
CPRA
PRIORITY ACTION WRITTEN
10/04/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/03/2017
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/19/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/30/2017
DOCK
ASSIGNED TO EXAMINER
08/29/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/07/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/06/2017
NWAP
NEW APPLICATION ENTERED
06/02/2017
Continuous trademark protection
Get notified about every new filing that threatens SALONPAS LIDOCAINE PLUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.